Physician profile
Carl A Hess
NPI 1154471118
$2,160.97
in general payments reported to CMS, 2019-2025
29 companies · $79.52 in 2025
The $79.52 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $637 · 2020: $495 · 2021: $225 · 2022: $76.91 · 2023: $207 · 2024: $441 · 2025: $79.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $381.78 | 2019-2025 | Xtampza |
| Biodelivery Sciences International, INC. | $265.67 | 2019-2021 | |
| Medtronic, INC. | $203.77 | 2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $144.51 | 2023 | |
| Nevro Corp. | $140.68 | 2019-2024 | Senza |
| Ziehm-Orthoscan, INC. | $128.16 | 2019-2020 | |
| Pfizer INC. | $89.51 | 2019-2024 | |
| Arbor Pharmaceuticals, INC. | $71.38 | 2019-2021 | |
| Forte Bio-Pharma LLC | $65.27 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $63.03 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.59 | 2020 | |
| Eisai INC. | $52.19 | 2021 | |
| Redhill Biopharma INC. | $50.05 | 2020-2021 | |
| Medtronic USA, INC. | $48.45 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $42.83 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $42.81 | 2024 | Procare |
| West Therapeutics Development, LLC | $40.71 | 2020 | |
| Merz Pharmaceuticals, LLC | $37.40 | 2024 | Xeomin |
| Almatica Pharma LLC | $37.23 | 2020-2021 | |
| Valinor Pharma, LLC | $29.62 | 2023-2024 | Movantik |
| Assertio Therapeutics, INC. | $29.05 | 2019 | |
| Vertos Medical, INC. | $27.26 | 2024 | Mild Device Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $21.43 | 2022 | |
| Stimwave Technologies Incorporated | $20.00 | 2019 | |
| Avanos Medical | $17.86 | 2025 | |
| Zyla Life Sciences, INC. | $16.77 | 2020 | |
| Sentynl Therapeutics, INC. | $13.60 | 2019 | |
| Horizon Therapeutics Plc | $11.86 | 2021 | |
| Electronic Waveform Lab, INC. | $9.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.